Download
1 / 6
60 likes | 83 Views
Respiratory Disease Testing Market should witness substantial growth due to increased prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma over the last few years. Increasing pollution and tobacco consumption coupled with rising geriatric population base and technological advancement in respiratory devices should drive respiratory disease testing market size over the forecast period.
E N D
Respiratory Disease Testing Market size is projected to experience significant growth from 2017 to 2024. : Global Market Insights Inc. Fuel Cell Market size worth $25.5bn by 2024 Low Power Wide Area Network
Regional Analysis of Respiratory Disease Testing Market: • Respiratory disease testing market should witness substantial growth due to increased prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma over the last few years. • Increasing pollution and tobacco consumption coupled with rising geriatric population base and technological advancement in respiratory devices should drive respiratory disease testing market size over the forecast period. • According to the International Respiratory Societies Forum, in 2014, over 200 million people across the world had COPD and nearly 235 million people were suffering from asthma. Furthermore, over 50 million individuals struggle with occupational lung disorder every year. • These factors should drive respiratory disease testing market growth. Increasing healthcare expenses and reimbursement concern may restrain the industry growth during the forecast period. Low adoption rate of portable spirometers and digital radiography can also hinder the respiratory disease testing market size.
Imaging tests includes x-rays, computed tomography (CT), magnetic resonance imaging, nuclear scanning, ultrasonography, and positron emission tomography (PET) scanning. Chest x-rays provide detailed framework of the heart and major blood vessels, it can also reveal serious disorder in the lungs and chest wall. • Chest x-ray reveal chronic obstructive pulmonary disease, pneumonias, atelectasis, lung tumors and pneumothorax or pleural effusion in the pleural space. It helps doctors to determine other tests required for the diagnosis. Measurement devices include respirometers, spirometers, capnographs, pulse oximeters and peak flowmeters. • Demand for pulse oximeters is rising in comparison with other devices due to precise and effective diagnosis in short time and increasing adoption for these testing devices by physicians.
Competitive Market Share of Respiratory Disease Testing Market • Insulin market estimated to foresee lucrative growth due to rising awareness about product and self-administration of insulin coupled with favorable reimbursement policies. • GLP-1 therapy will witness healthy growth in future due to its ability to minimize blood glucose level in patients with target disease. Homecare will be the major end user of the pen needles owing to self-administration of insulin on daily basis. • Hospital segment is anticipated to witness healthy growth in the coming few years due to availability of highly-skilled professionals and the quality of patient care provided.
Browse Full Market Research Report On Respiratory Disease Testing Market@ http://bit.ly/2uuKfIR Request for an in-depth table of contents for this report @ http://bit.ly/2tPdW4E
Stay In Touch Website: www.gminsights.com Social Media:
